Skip to main content

Another sad anniversary

It?s been a summer of depressing anniversaries, but not until now have I had the occasion to remember, vividly, the actual events. I was too young to remember the first reports of linkurl:AIDS, 25 years ago.;https://www.the-scientist.com/article/display/23586/ Legionnaire?s disease, happened (just a few blocks from where I now work) linkurl:five years earlier;https://www.the-scientist.com/blog/display/88/ than that. But I still remember quite vividly watching President Bush give his linkurl:firs

Written byBrendan Maher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
It?s been a summer of depressing anniversaries, but not until now have I had the occasion to remember, vividly, the actual events. I was too young to remember the first reports of linkurl:AIDS, 25 years ago.;https://www.the-scientist.com/article/display/23586/ Legionnaire?s disease, happened (just a few blocks from where I now work) linkurl:five years earlier;https://www.the-scientist.com/blog/display/88/ than that. But I still remember quite vividly watching President Bush give his linkurl:first address that specifically affected the life science community.;https://www.the-scientist.com/article/display/19830/ Five years ago today Bush said that he had spent months educating himself on the subject and searching his soul to finally decide that 60 was a good number of embryonic stem cell lines for people to work on with federal funds. It was one of those few times I ever experienced something both better than I could have hoped and worse than I could have imagined. I didn?t for a second suspect he would budge an inch on embryonic stem cells, so I was surprised to see him offering anything. But the announcement of freeing some funds, $250,000 at the time, for an arbitrary set of lines was a slap in the face to the hundreds of scientists he pretended to know better than. I find it striking how little has happened in five years. The optimist in me wanted to believe that this was, as some commentaries called it, a step in the right direction. But it wasn't. A vast majority of the lines were useless for research. Some got tied up in patent battles. States that have tried to pick up the funding slack have found their own share of landmines. Researchers who had to perform locational gymnastics to keep their federally funded work separated from their ES cell work still have to leap from room to room or building to building to stay 'legal.' And this past month, the first linkurl:Bush-vetoed bill;https://www.the-scientist.com/news/display/23995/ from a Republican-controlled House and Senate was on the very same topic. This was no indication of future direction, just a flimsy bone for researchers to choke on. The decision, five years ago, struck me as a poor effort to make good on his inaugural promise to mend the deep partisan divide after a controversial election. Although the events that day pale in comparison to another five year anniversary we Americans will be mourning later this year -- 9/11 -- its imprint is etched in my mind, nonetheless. Does anyone else care to share their memories?
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo